Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery

Hypotension Clinical Trial

Official title:

Randomized Double-blinded Comparison of Norepinephrine and Phenylephrine in Bolus for Maintenance of Blood Pressure During Spinal Anesthesia for Cesarean Delivery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03702400
• Other study ID #: 000.603
• Status: Completed
• Phase: Phase 2
• Start date: October 1, 2018
• Est. completion date: October 1, 2020

Study information

• Verified date: April 2021
• Source: Hospital dos Servidores do Estado do Rio de Janeiro
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluate the ability of phenylephrine and of noradrenaline to maintain normal systemic arterial blood pressure and heart rate in healthy pregnant women submitted to cesarean section with spinal anesthesia. Half of participants will receive bolus of phenylephrine while the other half will receive bolus of noradrenaline.

Description:

This is a prospective, randomized, double-blind, comparative two-group clinical study to observe two vasopressor drugs, phenylephrine and noradrenaline, in the ability to maintain systemic arterial pressure in pregnant women after spinal anesthesia for cesarean section; based on the hypothesis that, since noradrenaline has a predominant alpha-adrenergic action and a weak 1- beta-adrenergic beta action, it could be as capable of maintaining blood pressure effectively as phenylephrine, but with a lower frequency of bradycardia; patients who meet the inclusion criteria will be randomly assigned to one of the groups to be studied: group F - phenylephrine at a dose of 100mcg bolus and N - noradrenaline at the dose of 5mcg. One of these drugs will be used whenever systolic blood pressure drops below 10% of the baseline, additional doses will be allowed whenever necessary, aiming at maintaining the systolic blood pressure at baseline values; the blood pressure will be measured non-invasively and the heart rate by pulse oximeter and electrocardiogram.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 72
• Est. completion date: October 1, 2020
• Est. primary completion date: June 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Pregnant women, with single gestation, with cesarean programming to be performed under spinal anesthesia;

• Age above 18 years;

• Physical State American Society of Anesthesiologists (ASA) II and III;

• Weight between 50kg and 120kg;

• Height between 140cm and 180cm.

Exclusion Criteria:

• Refusal to participate in the study;

• Pregnant women with fetus with known abnormalities;

• Pregnant women with cardiovascular disease;

• Pregnant women with pregnancy-specific hypertensive disease;

• Allergy to any medication to be used in the study;

• Users of monoamine oxidase inhibitors;

• Users of tricyclic antidepressants;

• Emergency caesarean section due to acute fetal distress;

• Situations in which the sensory level after single intrathecal injection of the local anesthetic does not reach at least T6 within 5 minutes after spinal anesthesia.

Related Conditions & MeSH terms

• Hypotension
• Spinal Anesthesia

Intervention

Drug:
• Phenylephrine 100 mcg
Phenylephrine at a dose of 100 mcg bolus at a dilution containing 20 mcg / mL of the drug, 5 mL each bolus
• Norepinephrine 5 mcg
Norepinephrine at a dose of 5 mcg at dilution containing 1 mcg / mL, 5 mL each bolus

Locations

Country	Name	City	State
Brazil	Hospital Federal Dos Servidores Do Estado	Rio De Janeiro	RJ

Sponsors (1)

Lead Sponsor	Collaborator
Hospital dos Servidores do Estado do Rio de Janeiro

Country where clinical trial is conducted

Brazil, 

References & Publications (2)

Ngan Kee WD, Lee SW, Ng FF, Tan PE, Khaw KS. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery. Anesthesiology. 2015 Apr;122(4):736-45. doi: 10.1097/ALN.0000000000000601. — View Citation

Vallejo MC, Attaallah AF, Elzamzamy OM, Cifarelli DT, Phelps AL, Hobbs GR, Shapiro RE, Ranganathan P. An open-label randomized controlled clinical trial for comparison of continuous phenylephrine versus norepinephrine infusion in prevention of spinal hypotension during cesarean delivery. Int J Obstet Anesth. 2017 Feb;29:18-25. doi: 10.1016/j.ijoa.2016.08.005. Epub 2016 Aug 28. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of bolus required	Number of bolus doses of phenylephrine and noradrenaline to maintain systemic arterial pressure at 90% of baseline in pregnant women undergoing spinal anesthesia for cesarean	during the procedure
Primary	Heart rate	Number of episodes of heart rate under 60 bpm while using phenylephrine and noradrenaline in pregnant women undergoing spinal anesthesia for cesarean	during the procedure
Secondary	Neonatal gasometric outcome	To evaluate the neonatal outcome through the analysis of venous and arterial blood gases collected in the cord umbilical after birth.	during the procedure
Secondary	Neonatal Apgar outcome	To evaluate the neonatal outcome through the classification given by the neonatologist responsible for the care to the newborn in the delivery room with the use of the Apgar Scale (0-10), 10 the better classification.	during the procedure
Secondary	Nausea and vomiting	To evaluate the incidence of nausea and vomiting of the parturient during cesarean section	during the procedure